Honey Versus Povidone-iodine on Laceration Wounds

NCT ID: NCT03641053

Last Updated: 2018-08-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

35 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-01-29

Study Completion Date

2018-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study evaluates healing time in usage of honey and povidone-iodine over paraffin gauze as dressings in the treatment of acute laceration wounds. In Indonesia, especially in rural area, where most of the resources is limited and modern dressings are expensive and hard-to-find. The investigators tried to find an alternative which was easier to find and could act as a substitute of modern wound dressing.

The hypothesis of this study is honey and povidone-iodine could be a good substitute (or equal to) to paraffin gauze on acute laceration wounds.

Honey is chosen because of its versatility and already well-known to be used as a chronic wound dressing. Povidone-iodine was chosen as another alternative because it is still one of the most used substance in rural area as a wound dressing, but there is not enough study to support the usage of this substance. Paraffin gauze was chosen as a representative of modern wound dressing because it fulfilled the standard of wound dressing on acute wound, which is non-adherent and also moist.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The investigator's team consists of five members, each have their own specific tasks and divided by two groups, which are ER group (first time encounter, informed consent, and intervention) and polyclinic group (routine wound care). All of the data are primary data. Data registry were taken by the team without involving any other party. Any intervention done to the participants were also done only by the team(suturing, wound care). Appointment for routine wound care was also made by contacting the participant through their cellphone numbers which were collected when they come to the ER.

The data of each of the participant was registered on a form which was pre-made by the investigators. It recorded the identity of the patient, history taking, physical examination, and also to record more detailed information about our intervention, such as the amount of stitches and how many and what kind of resources that have been spent on the participant.

Every sample will be categorized into 3 randomized groups of intervention; honey, povidone-iodine, and paraffin gauze, which will also be categorized by location of their wound; face and neck, upper extremity, and lower extremity. Participants on each intervention group are distributed evenly using stratified block randomization. Photos of the wound will be taken before and after the wound is cleaned, and after the wound has been sutured. Every patient will be asked to attend a predetermined schedule for wound care assessment. The wound will be evaluated by photos before and after the wound is cleaned, debrided, or have its sutures removed. Parameter of evaluation will be duration of wound healing per anatomical region, infection, cleanliness of wound, odor, exudate level, pain, itch, and total cost of wound care.

Every paper consists of participants' data that were collected on colored maps based on the intervention group (red: povidone-iodine, yellow: honey, blue: paraffin). At the end of the study, three of the team's members converted the data to be analyzed using Microsoft Excel and SPSS.

The investigators prepared beforehand the Standard Operational Procedures regarding any possibilities of adverse events, such as lidocaine toxicity and honey hypersensitivity and were already approved by the hospital's committee.

The investigators determined the target of the sample size with the total sample of 36 participants, distributed evenly based on intervention groups and wounds' location using stratified block randomization

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Laceration Face Wound Heal Wounds and Injuries Laceration Arm Laceration of Leg

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

A three-arm parallel assignment where one group receives honey, the second group receives povidone-iodine, and the third group receives paraffin gauze as wound dressing.
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants
Participants do not know which intervention substance they have been assigned to

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Honey

0.05 cc of honey (Madu Nusantara®) per 1 cm of laceration, given every predetermined wound care schedule

Group Type EXPERIMENTAL

Honey

Intervention Type OTHER

Substance is given topically after the wound has been sutured

Povidone-iodine

0.05 cc of povidone-iodine per 1 cm of laceration, given every predetermined wound care schedule

Group Type ACTIVE_COMPARATOR

Povidone-iodine

Intervention Type OTHER

Substance is given topically after the wound has been sutured

Paraffin gauze

1 layer of paraffin gauze, given every predetermined wound care schedule

Group Type ACTIVE_COMPARATOR

Paraffin gauze

Intervention Type OTHER

Substance is given topically after the wound has been sutured

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Honey

Substance is given topically after the wound has been sutured

Intervention Type OTHER

Povidone-iodine

Substance is given topically after the wound has been sutured

Intervention Type OTHER

Paraffin gauze

Substance is given topically after the wound has been sutured

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Madu Nusantara® OneMed® povidone-iodine 10% Cuticell® Classic Paraffin Gauze

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Every patient that admits to the emergency department with:

* An acute open traumatic wound
* Agrees to a voluntary agreement for informed consent
* To be treated in an outpatient setting

Exclusion Criteria

Human factor:

* Patient under the age of 10 and over 60 years old
* Systemic conditions (diabetes mellitus, hypertension, liver' kidney disease)
* Signs of infection
* Consuming steroids and / or antibiotics
* History of keloid
* History of drug and / or alcohol abuse
* Under treatment for chemotherapy or immunocompromised
* Pregnant
* History of allergy towards amoxicillin and / or ibuprofen

Wound factor:

* Acute Open Traumatic Wound that has occured after than 12 hours of admittance to the emergency department
* Open fracture
* Suspicion of contamination from the mechanism of attaining the wound (human or animal bite, body fluids such as faeces, saliva, urine, sperm, or vaginal secretion)
* Penetration trauma (stab wound, gunshot wound, or a joint-affected wound)
* Signs of wound infection
* More than one wound in the same anatomical region
* Possess a chronic wound caused by underlying disease other than trauma
* Wound with exposed tendon and/ or bone
* Wound length dimension no less than 1 cm and no more than 10 cm.
* Hypersensitivity to honey
* Does not attend to scheduled wound care assesment control
* Sample's wish to not be involved anymore with the research at any phase
Minimum Eligible Age

10 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

S.K. Lerik General Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Kevin Leonard Suryadinata

Kevin Leonard Suryadinata, MD. Principal Investigator and General Practitioner of S.K. Lerik General Hospital

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Kevin L Suryadinata, MD

Role: PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

S.K. Lerik General Hospital

Kupang, East Nusa Tenggara, Indonesia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Indonesia

References

Explore related publications, articles, or registry entries linked to this study.

Fife CE, Carter MJ. Wound Care Outcomes and Associated Cost Among Patients Treated in US Outpatient Wound Centers: Data From the US Wound Registry. Wounds. 2012 Jan;24(1):10-7.

Reference Type BACKGROUND
PMID: 25875947 (View on PubMed)

Sood A, Granick MS, Tomaselli NL. Wound Dressings and Comparative Effectiveness Data. Adv Wound Care (New Rochelle). 2014 Aug 1;3(8):511-529. doi: 10.1089/wound.2012.0401.

Reference Type BACKGROUND
PMID: 25126472 (View on PubMed)

Dhivya S, Padma VV, Santhini E. Wound dressings - a review. Biomedicine (Taipei). 2015 Dec;5(4):22. doi: 10.7603/s40681-015-0022-9. Epub 2015 Nov 28.

Reference Type BACKGROUND
PMID: 26615539 (View on PubMed)

Indonesia | Data. Indonesia [Internet]. 2017 [updated 2017; cited 2017 Jun 18]. Available from: http://data.worldbank.org/country/indonesia.

Reference Type BACKGROUND

Trihono. Riset Kesehatan Dasar: Riskesdas 2013. Jakarta: Badan Penelitian dan Pengembangan Kesehatan Kementerian Kesehatan RI.

Reference Type BACKGROUND

Produk Domestik Bruto - Analisis PDB Per Kapita Indonesia | Indonesia Investments. Produk Domestik Bruto Indonesia [Internet]. 2017 [updated 2017 Feb 6; cited 2017 Jun 18]. Available from: https://www.indonesia-investments.com/id/keuangan/angka-ekonomi-makro/produk-domestik-bruto-indonesia/item253.

Reference Type BACKGROUND

Badan Pusat Statistik. Upah Minimum Regional/Provinsi (UMR/UMP) dan rata-rata Nasional per tahun (Dalam Rupiah), 1997-2016 [Internet]. Jakarta: Badan Pusat Statistik; 2016 [updated 2016; cited 2017 Jun 18]. Available from: https://www.bps.go.id/linkTableDinamis/view/id/917

Reference Type BACKGROUND

Moeloek NF. Peraturan Menteri Kesehatan Republik Indonesia Nomor 4 Tahun 2017 Tentang Perubahan Kedua Atas Peraturan Menteri Kesehatan Nomor 52 Tahun 2016 Tentang Standar Tarif Pelayanan Kesehatan Dalam Penyelenggaraan Program Jaminan Kesehatan. Jakarta: Menteri Kesehatan Republik Indonesia; 2017. pg. 6.

Reference Type BACKGROUND

Hemani ML, Lepor H. Skin preparation for the prevention of surgical site infection: which agent is best? Rev Urol. 2009 Fall;11(4):190-5.

Reference Type BACKGROUND
PMID: 20111631 (View on PubMed)

Angel DE, Morey P, Storer JG, Mwipatayi BP. The great debate over iodine in wound care continues: a review of the literature. Wound Pract Res. 2008;16(1):6-21.

Reference Type BACKGROUND

Jull AB, Walker N, Deshpande S. Honey as a topical treatment for wounds. Cochrane Database Syst Rev. 2013 Feb 28;(2):CD005083. doi: 10.1002/14651858.CD005083.pub3.

Reference Type BACKGROUND
PMID: 23450557 (View on PubMed)

Saikaly SK, Khachemoune A. Honey and Wound Healing: An Update. Am J Clin Dermatol. 2017 Apr;18(2):237-251. doi: 10.1007/s40257-016-0247-8.

Reference Type BACKGROUND
PMID: 28063093 (View on PubMed)

Nevas M, Lindstrom M, Horman A, Keto-Timonen R, Korkeala H. Contamination routes of Clostridium botulinum in the honey production environment. Environ Microbiol. 2006 Jun;8(6):1085-94. doi: 10.1111/j.1462-2920.2006.001000.x.

Reference Type BACKGROUND
PMID: 16689729 (View on PubMed)

Shukrimi A, Sulaiman AR, Halim AY, Azril A. A comparative study between honey and povidone iodine as dressing solution for Wagner type II diabetic foot ulcers. Med J Malaysia. 2008 Mar;63(1):44-6.

Reference Type BACKGROUND
PMID: 18935732 (View on PubMed)

Gulati S, Qureshi A, Srivastava A, Kataria K, Kumar P, Ji AB. A Prospective Randomized Study to Compare the Effectiveness of Honey Dressing vs. Povidone Iodine Dressing in Chronic Wound Healing. Indian J Surg. 2014 Jun;76(3):193-8. doi: 10.1007/s12262-012-0682-6. Epub 2012 Jul 12.

Reference Type BACKGROUND
PMID: 25177115 (View on PubMed)

Li J, Chen J, Kirsner R. Pathophysiology of acute wound healing. Clin Dermatol. 2007 Jan-Feb;25(1):9-18. doi: 10.1016/j.clindermatol.2006.09.007.

Reference Type BACKGROUND
PMID: 17276196 (View on PubMed)

Thorne CHM, Gurtner GC, Chung K, Gosain A Mehrara B, Rubin P, Spear SL Grabb and Smith's Plastic Surgery. 7th ed.. Lippincott Williams & Wilkins, Philadelphia, USA. Pg. 14-17.

Reference Type BACKGROUND

Siddiqui AR, Bernstein JM. Chronic wound infection: facts and controversies. Clin Dermatol. 2010 Sep-Oct;28(5):519-26. doi: 10.1016/j.clindermatol.2010.03.009.

Reference Type BACKGROUND
PMID: 20797512 (View on PubMed)

Kumar V, Cotran RS, Robbin ST. Robbins basic Pathology. 7th ed. Philadelphia, 2003, Saunders.

Reference Type BACKGROUND

Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med. 1999 Sep 2;341(10):738-46. doi: 10.1056/NEJM199909023411006. No abstract available.

Reference Type BACKGROUND
PMID: 10471461 (View on PubMed)

Troxler M, Vowden K, Vowden P. 2006. Integrating Adjunctive Therapy into Practice: The Importance of Recofnising 'Hard-to-Heal' Wounds.

Reference Type BACKGROUND

Lazarus GS, Cooper DM, Knighton DR, Percoraro RE, Rodeheaver G, Robson MC. Definitions and guidelines for assessment of wounds and evaluation of healing. Wound Repair Regen. 1994 Jul;2(3):165-70. doi: 10.1046/j.1524-475X.1994.20305.x.

Reference Type BACKGROUND
PMID: 17156107 (View on PubMed)

Fonseca JA et al. Medscape Education. Burn Wound Infections. [Online]. Updated May 25, 2016. Available at http://emedicine.medscape.com/article/213595-overview. Accessed June 16, 2017.

Reference Type BACKGROUND

Nicks BA, Ayello EA, Woo K, Nitzki-George D, Sibbald RG. Acute wound management: revisiting the approach to assessment, irrigation, and closure considerations. Int J Emerg Med. 2010 Aug 27;3(4):399-407. doi: 10.1007/s12245-010-0217-5.

Reference Type BACKGROUND
PMID: 21373312 (View on PubMed)

Yaghoobi R, Kazerouni A, Kazerouni O. Evidence for Clinical Use of Honey in Wound Healing as an Anti-bacterial, Anti-inflammatory Anti-oxidant and Anti-viral Agent: A Review. Jundishapur J Nat Pharm Prod. 2013 Aug;8(3):100-4. doi: 10.17795/jjnpp-9487. Epub 2013 Jul 17.

Reference Type BACKGROUND
PMID: 24624197 (View on PubMed)

Kaufman T, Eichenlaub EH, Angel MF, Levin M, Futrell JW. Topical acidification promotes healing of experimental deep partial thickness skin burns: a randomized double-blind preliminary study. Burns Incl Therm Inj. 1985 Dec;12(2):84-90. doi: 10.1016/0305-4179(85)90032-4.

Reference Type BACKGROUND
PMID: 4092157 (View on PubMed)

Greener B, Hughes AA, Bannister NP, Douglass J. Proteases and pH in chronic wounds. J Wound Care. 2005 Feb;14(2):59-61. doi: 10.12968/jowc.2005.14.2.26739. No abstract available.

Reference Type BACKGROUND
PMID: 15739652 (View on PubMed)

Biswas A, Bharara M, Hurst C, Gruessner R, Armstrong D, Rilo H. Use of sugar on the healing of diabetic ulcers: a review. J Diabetes Sci Technol. 2010 Sep 1;4(5):1139-45. doi: 10.1177/193229681000400512.

Reference Type BACKGROUND
PMID: 20920433 (View on PubMed)

Molan P, Rhodes T. Honey: A Biologic Wound Dressing. Wounds. 2015 Jun;27(6):141-51.

Reference Type BACKGROUND
PMID: 26061489 (View on PubMed)

Portenoy RK, Tanner RM. Pain Management: Theory and Practice. Oxford: Oxford University Press; 1996.

Reference Type BACKGROUND

Bijur PE, Latimer CT, Gallagher EJ. Validation of a verbally administered numerical rating scale of acute pain for use in the emergency department. Acad Emerg Med. 2003 Apr;10(4):390-2. doi: 10.1111/j.1553-2712.2003.tb01355.x.

Reference Type BACKGROUND
PMID: 12670856 (View on PubMed)

Williamson A, Hoggart B. Pain: a review of three commonly used pain rating scales. J Clin Nurs. 2005 Aug;14(7):798-804. doi: 10.1111/j.1365-2702.2005.01121.x.

Reference Type BACKGROUND
PMID: 16000093 (View on PubMed)

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Document Type: Informed Consent Form

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SKL001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.